ORCHESTRATING THE IMMUNE SYSTEM

WIPO WIPO 2023

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark ORCHESTRATING THE IMMUNE SYSTEM was filed as Word mark on 01/24/2023 at the World Intellectual Property Organization.

Trademark Details Last update: July 28, 2023

Trademark form Word mark
File reference 1716349
Countries Canada China United Kingdom Japan
Base trademark US No. 97518230, July 25, 2022
Application date January 24, 2023
Expiration date January 24, 2033

Trademark owner

410 W Harrison Street, Suite 150
Seattle WA 98119
US

Trademark representatives

801 California Street, Silicon Valley Center US

goods and services

05 Pharmaceutical products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, gastrointestinal diseases and disorders, and other related diseases and disorders; biological products and preparations, for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; cell therapy products and preparations for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; therapeutic products and preparations, for the prevention and treatment of diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; pharmaceutical, biological, cell therapy, therapeutic and medicinal products and preparations for use in combination with other therapies for the treatment and prevention diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; diagnostic biomarker reagents for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases, cancer and other related diseases and disorders; diagnostic agents, preparations, and substances for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer, gastrointestinal diseases and disorders, and other related diseases and disorders
42 Pharmaceutical research and development in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; medical, pharmaceutical, therapeutic and scientific research in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; medical, pharmaceutical, therapeutic and scientific research in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; clinical research and testing in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; clinical research and testing in the field of biomarkers for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders; conducting clinical trials in the field of autoimmune diseases and disorders, inflammatory diseases and disorders, infectious diseases and disorders, cancer gastrointestinal diseases and disorders, and other related diseases and disorders; providing medical, clinical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosing, preventing, and treating diseases and disorders, namely, autoimmune diseases and disorders, inflammatory diseases and disorders, gastrointestinal diseases and disorders, infectious diseases and disorders, cancer and other related diseases and disorders

Trademark history

Date Document number Area Entry
July 26, 2023 2023/30 Gaz CN Rejection
May 23, 2023 2023/21 Gaz Deletion
March 31, 2023 2023/15 Gaz EM Rejection
January 24, 2023 2023/7 Gaz US Registration

ID: 141716349